glp 1 for diabetes GLP-1 Weight Loss and GLP-1 use tripled among non-diabetics,
Description
2017: The FDA approves Novo Nordisks Ozempic to treat diabetes
report a decreased risk of RGC in patients on GLP-1 RAs undergoing concurrent EGD and colonoscopy when compared to EGD alone (protection ratio (PR) = 0.25, confidence interval 0.160.39) [16]
doi: 10.1016/j.molmet.2018.09.009
Lastly, sticking closely to the prescribed treatment schedule is crucial for maximizing effectiveness
There is a lot of noise when it comes to these medications, however, with people ending up scared, and others expecting miracles out of them only to end up with disappointment
